1.
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial
by Koopman, Miriam, MD
The Lancet (British edition), 2007, Vol.370 (9582), p.135-142
2.
Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group
by Simkens, Lieke H J, MD
The Lancet (British edition), 2015, Vol.385 (9980), p.1843-1852
3.
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizu...
by Tabernero, Josep, Dr
The lancet oncology, 2015, Vol.16 (5), p.499-508
4.
Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC–GELA H8 randomised controlled trial
by Heutte, Natacha, PhD
The lancet oncology, 2009, Vol.10 (12), p.1160-1170
